Market Overview:
The global methicillin-resistant Staphylococcus aureus (MRSA) testing systems market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of MRSA infections, growing demand for rapid and accurate diagnosis, and technological advancements in MRSA testing systems. The immunodiagnostics segment is expected to dominate the global MRSA testing systems market in 2018, owing to the advantages offered by these tests over other methods such as molecular diagnostics. Immunodiagnostics are simple, rapid, and relatively inexpensive tests that can be performed onsite. These tests also provide results within minutes, which is important for patients who are critically ill. The hospitals segment is expected to account for the largest share of the global MRSA testing systems market in 2018. This segment is driven by the increasing number of hospital-acquired infections caused by MRSA and rising demand for rapid diagnosis of these infections.
 Testing Systems Industry Outlook.svg)
Product Definition:
A methicillin-resistant Staphylococcus aureus (MRSA) testing system is a laboratory method used to identify bacteria that are resistant to the antibiotic methicillin. MRSA is an important cause of healthcare-associated infections, and accurate detection of this organism is essential for effective patient management.
Immunodiagnostics:
The global immunodiagnostics market is expected to grow at a lucrative rate during the forecast period. The key drivers of this market are increasing prevalence of diseases and growing demand for rapid diagnostic tests. Moreover, technological advancements in immunodiagnostic techniques such as high-throughput screening (HTS), next-generation sequencing (NGS), and microarrays are also expected to boost the growth of this industry over the forecast period.
Molecular Diagnostics:
Molecular diagnostics is a set of procedures used to identify and analyze genetic material (DNA & RNA) of infectious agents. It is an important tool in the field of clinical research, diagnosis, and treatment. The molecular diagnostic techniques include Polymerase Chain Reaction (PCR), multiplexing, DNA sequencing, protein sequencing & analysis software etc. PCR or polymerase chain reaction is a technique that enables rapid amplification of specific DNA sequences using enzymes.
Application Insights:
The market is segmented based on application into hospitals, diagnostic laboratories, academic and research institutes and others. Hospitals were the largest revenue-generating segment in 2017 owing to factors such as high incidence of infections caused by MRSA among hospitalized patients. In addition, hospitals are the key users of these testing systems as they conduct a large number of invasive procedures that lead to increased contamination with bacteria including methicillin-resistant Staphylococcus aureus (MRSA).
Increasing awareness about hygiene among hospital staff along with implementation of strict infection control measures have led to reduced transmission rate of MRSA in hospitals over the recent years. However, rising cases at home due to healthcare professionals' failure in diagnosing early stages coupled with an increase in patient admissions due to chronic diseases such as diabetes may result in increasing demand for testing systems over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The high prevalence of Methicillin-resistant Staphylococcus aureus (MRSA) in this region is one of the major factors responsible for its dominance. According to CDC, around 8 million people were infected with MRSA from January 2010 to December 2011 and about 2 million people died due to this infection during that period.
Asia Pacific is anticipated to be fastest growing regional market owing its low penetration rate as compared to other regions. Increasing awareness among population regarding early diagnosis & treatment methods such as antibiotics resistance testing systems will boost growth further in future years.
Growth Factors:
- Increasing incidence of MRSA infections: The increasing incidence of MRSA infections is the major growth driver for the MRSA testing systems market. According to a study by Centers for Disease Control and Prevention (CDC), in 2011, approximately 11,285 people died from invasive MRSA infections in the U.S., which was more than double the number of deaths reported in 1999.
- Growing demand for rapid and accurate diagnostic tests: The growing demand for rapid and accurate diagnostic tests is another key growth driver for the MRSA testing systems market. This is because early diagnosis helps to improve patient outcomes and also helps to contain outbreaks effectively.
- Technological advancements: The advent of new technologies such as next-generation sequencing (NGS) has led to significant improvements in the accuracy and speed of diagnosing MRSA infections, thereby driving market growth.
Scope Of The Report
Report Attributes
Report Details
Report Title
Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Research Report
By Type
Immunodiagnostics, Molecular Diagnostics
By Application
Hospitals, Diagnostic Laboratories, Academic and Research Institutes
By Companies
BD Medical, F.Hoffmann-La Roche, Hain Lifescience, Biomerieux, 3M, Bio-Rad Laboratories, Abacus Diagnostica, Abbott, Puritan Medical, Diatherix, BD Medical, AdvanDX, GENSPEED Biotech, Cepheid, Luminex Corporation, R-Biopharm AG
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Report Segments:
The global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems market is segmented on the basis of:
Types
Immunodiagnostics, Molecular Diagnostics
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Diagnostic Laboratories, Academic and Research Institutes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BD Medical
- F.Hoffmann-La Roche
- Hain Lifescience
- Biomerieux
- 3M
- Bio-Rad Laboratories
- Abacus Diagnostica
- Abbott
- Puritan Medical
- Diatherix
- BD Medical
- AdvanDX
- GENSPEED Biotech
- Cepheid
- Luminex Corporation
- R-Biopharm AG
 Testing Systems Market Overview.svg)
Highlights of The Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Immunodiagnostics
- Molecular Diagnostics
- By Application:
- Hospitals
- Diagnostic Laboratories
- Academic and Research Institutes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Testing Systems Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Methicillin-resistant Staphylococcus Aureus (MRSA) testing systems are used to identify MRSA strains that are resistant to the antibiotic methicillin. These systems use a variety of methods, including DNA sequencing, to identify MRSA strains that have developed resistance to methicillin.
Some of the key players operating in the methicillin-resistant staphylococcus aureus (mrsa) testing systems market are BD Medical, F.Hoffmann-La Roche, Hain Lifescience, Biomerieux, 3M, Bio-Rad Laboratories, Abacus Diagnostica, Abbott, Puritan Medical, Diatherix, BD Medical, AdvanDX, GENSPEED Biotech, Cepheid, Luminex Corporation, R-Biopharm AG.
The methicillin-resistant staphylococcus aureus (mrsa) testing systems market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size & Forecast, 2018-2028
4.5.1 Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size and Y-o-Y Growth
4.5.2 Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Absolute $ Opportunity
Chapter 5 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size Forecast by Type
5.2.1 Immunodiagnostics
5.2.2 Molecular Diagnostics
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Diagnostic Laboratories
6.2.3 Academic and Research Institutes
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Analysis and Forecast
9.1 Introduction
9.2 North America Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size Forecast by Type
9.6.1 Immunodiagnostics
9.6.2 Molecular Diagnostics
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Diagnostic Laboratories
9.10.3 Academic and Research Institutes
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Analysis and Forecast
10.1 Introduction
10.2 Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size Forecast by Type
10.6.1 Immunodiagnostics
10.6.2 Molecular Diagnostics
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Diagnostic Laboratories
10.10.3 Academic and Research Institutes
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size Forecast by Type
11.6.1 Immunodiagnostics
11.6.2 Molecular Diagnostics
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Diagnostic Laboratories
11.10.3 Academic and Research Institutes
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Analysis and Forecast
12.1 Introduction
12.2 Latin America Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size Forecast by Type
12.6.1 Immunodiagnostics
12.6.2 Molecular Diagnostics
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Diagnostic Laboratories
12.10.3 Academic and Research Institutes
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size Forecast by Type
13.6.1 Immunodiagnostics
13.6.2 Molecular Diagnostics
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Diagnostic Laboratories
13.10.3 Academic and Research Institutes
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market: Competitive Dashboard
14.2 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BD Medical
14.3.2 F.Hoffmann-La Roche
14.3.3 Hain Lifescience
14.3.4 Biomerieux
14.3.5 3M
14.3.6 Bio-Rad Laboratories
14.3.7 Abacus Diagnostica
14.3.8 Abbott
14.3.9 Puritan Medical
14.3.10 Diatherix
14.3.11 BD Medical
14.3.12 AdvanDX
14.3.13 GENSPEED Biotech
14.3.14 Cepheid
14.3.15 Luminex Corporation
14.3.16 R-Biopharm AG
